Where AIRE we now? Where AIRE we going?

Patrick Bez,Martina Ceraudo,Fabrizio Vianello,Marcello Rattazzi,Riccardo Scarpa
DOI: https://doi.org/10.1097/aci.0000000000001041
2024-10-25
Current Opinion in Allergy and Clinical Immunology
Abstract:Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), known also as autoimmune polyendocrine syndrome type 1 (APS1), arises from damaging genetic germline mutations in the autoimmune regulator ( AIRE ) gene, leading to multiple autoimmune diseases in affected individuals. Since its discovery in 1997, studies on the AIRE gene have significantly advanced our understanding of fundamental aspects of human immunology. Specifically, these studies have been crucial in unraveling the basic mechanisms underlying the immune system's ability to distinguish between self and nonself. Indeed, AIRE plays a pivotal and distinctive role in the process of immunological tolerance by promoting the expression of a vast array of self-antigens within the thymus to the growing thymocytes [1] .
immunology,allergy
What problem does this paper attempt to address?